Hydroxychloroquine (Plaquenil®) was approved by the Food and Drug Administration for symptoms of lupus. The greatest concern people with lupus have when taking hydroxychloroquine is related to vision and an increase in risk for retinal damage. A new investigation analyzed the retinal changes over a five-year period in people with lupus and did not find clinically relevant retinal changes in the group. The study concludes that hydroxychloroquine therapy is safe for long-term use at doses <5 mg/kg/day. Learn about how lupus affects the eyes and hydroxychloroquine.
Lupus Foundation of America, Florida Chapter
2300 High Ridge Road, Suite 375
Boynton Beach, FL 33426
Main: 561.279.8606, Ext. 2
InfoLine: 855.90.LUPUS or 855.905.8787
There are multiple chapters near you. Select your preferred chapter.
Serving the District of Columbia, Maryland, and Northern Virginia.
Serving southern Illinois up to and including Springfield, eastern Kansas, and Missouri
Serving northern and central Illinois
Serving north, central and west Texas, including Dallas/Fort Worth, San Antonio, Austin, El Paso, Lubbock, and surrounding areas
Serving all northern counties in New Jersey, south through Mercer and Ocean counties
Supporting lupus patients and advocates in New York and Connecticut.
Serving Philadelphia and southeastern Pennsylvania, all southern counties in New Jersey up through Burlington county, and Delaware
Serving Houston, Beaumont, Corpus Christi, Harlingen and surrounding areas in Texas
There are multiple walks near you.